COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Fernando José Magro Dias

    Autor

  • Cândida Manuela Ferreira Abreu

    Autor

  • Diogo Miguel Pereira Libânio Monteiro

    Autor

Participantes de fora da FMUP

  • Nuzzo, A
  • Rodriguez Lago, I
  • Pawlak, K
  • Hollenbach, M
  • Brouwer, WP
  • Siau, K

Unidades de investigação

Abstract

Background The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients. Objective At this point, it is important to evaluate the impact of the pandemic on this field to further improve the quality of the services provided in this context. Methods/Results/Conclusion We performed a literature review that summarizes the main aspects to consider in gastroenterology, during the pandemic crisis, and includes a deep discussion on the main changes affecting gastroenterology patients and healthcare systems, anticipating the pandemic recovery scenario with future practices and policies.

Dados da publicação

ISSN/ISSNe:
2050-6406, 2050-6414

United European Gastroenterology Journal  John Wiley & Sons Inc.

Tipo:
Review
Páginas:
750-765
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 12

Citações Recebidas na Scopus: 16

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • COVID-19; endoscopy; gastroenterology; inflammatory bowel disease; SARS-CoV-2; vaccination

Financiamento

Proyectos asociados

Gut microbiome and IBD therapy: an interplay?

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (GutIBD) . 2021

Iron deficiency and inflammatory bowel disease. Correlation with inflammation and Vitamin D status.

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (IronIBD) . 2021

Looking 4WARD: The role of dipeptidyl peptidase 4 (DPP-4) in inflammatory bowel disease (IBD) as a novel biomarker for predicting disease activity and monitoring response to therapy in IBD patients.

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (4WARD) . 2021

Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação